Prof.Dr. ONUR KESKİN

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Risk of Bleeding After Percutaneous Endoscopic Gastrostomy in Patients Using Antithrombotic Drugs

PARLAR Y. E., Mustafayev F., Vahabov C., ŞAHİN T., İsrafilov S., KESKİN O., et al.

Surgical Laparoscopy, Endoscopy and Percutaneous Techniques , cilt.33, sa.5, ss.540-542, 2023 (SCI-Expanded)

Proceedings of the 27th Annual Congress of the International Liver Transplantation Society

Campos-Varela I., Rammohan A., Chadha R., Alconchel F., Hakeem A. R., Mathew J. S., et al.

Transplantation , cilt.107, sa.6, ss.1226-1231, 2023 (SCI-Expanded)

The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease

KESKİN O., Farisogullari B., YARDIMCI G. K., GÜRBÜZ B., Kole M., PARLAK E., et al.

Frontiers in Medicine , cilt.10, 2023 (SCI-Expanded)

The impact of COVID-19 disease on the natural course of cirrhosis: Before and after starting vaccination

KESKİN O., ORAL H., Sahin T., KAV T., PARLAK E.

Frontiers in Medicine , cilt.9, 2023 (SCI-Expanded)

Emerging drugs for hepatitis D

KESKİN O., Yurdaydin C.

Expert Opinion on Emerging Drugs , cilt.28, sa.2, ss.55-66, 2023 (SCI-Expanded)

Clinical and Endoscopic Consequences of Delay in Stent Exchange Procedures With ERCP During the Covid-19 Pandemic

Keskin O., Kav T., Vahabov C., Usta B., Sivri B., Parlak E.

Surgical laparoscopy, endoscopy & percutaneous techniques , cilt.32, sa.6, ss.714-719, 2022 (SCI-Expanded)

The role of preoperative psychosocial counselling on the improvement of the recipient compliance and speed of recovery after liver transplantation – A systematic review of the literature and expert panel recommendations

Weiss E., Kabacam G., Gorvin L., Spiro M., Raptis D. A., KESKİN O., et al.

Clinical Transplantation , cilt.36, sa.10, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Outcomes of Surgical Strategies for Living Donor Liver Transplantation in Patients With Portal Vein Thrombosis: A Cohort Study

KIRIMKER E. O., Kabacam G., KESKİN O., Goktug U. U., Atli M., KOLOĞLU M., et al.

Transplantation Proceedings , cilt.54, sa.8, ss.2217-2223, 2022 (SCI-Expanded)

Proceedings of the 26th Annual Virtual Congress of the International Liver Transplantation Society

Kalisvaart M., Chadha R., De Martin E., Alconchel F., Goldaracena N., KESKİN O., et al.

TRANSPLANTATION , cilt.106, sa.9, ss.1738-1744, 2022 (SCI-Expanded)

Quality of care for hepatitis B patients should include delta hepatitis screening

KESKİN O.

INTERNAL MEDICINE JOURNAL , cilt.52, sa.8, ss.1457, 2022 (SCI-Expanded)

The course of COVID-19 infection in patients with chronic hepatitis B and Delta

PARLAR Y. E., KESKİN O., KIRMIZIGÜL B., Gencdal G., Zeybel M., Gumussoy M., et al.

JOURNAL OF HEPATOLOGY , cilt.77, 2022 (SCI-Expanded)

Is the effect of coffee consumption on the development of fibrosis really different in treated and untreated hepatitis B patients?

KESKİN O.

CLINICAL NUTRITION , cilt.41, sa.6, ss.1445, 2022 (SCI-Expanded)

Hereditary angioedema and pancreatitis: two diseases that should remind each other

Ismayilov R., Ismayilova U., KESKİN O.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.34, sa.2, ss.240-241, 2022 (SCI-Expanded)

A NEW SCORING SYSTEM COMPOSED OF MMP-1, AST/ALT RATIO AND TOTAL METABOLIC SYNDROME SCORE CAN DETECT AT-RISK NASH PATIENTS WITH FIBROSIS STAGE >= 2 MORE ACCURATELY THAN FIB-4 SCORE, NAFLD FIBROSIS SCORE, BARD SCORE, APRI SCORE AND MR ELASTOGRAPHY

KÖYLÜ B., SÖKMENSÜER C., KESKİN O.

HEPATOLOGY , cilt.74, 2021 (SCI-Expanded)

Letter to the Editor: Interferon Is Not an Optimal Treatment for Chronic Hepatitis Delta but Needs "Fair Treatment" by Us

KESKİN O., Yurdaydin C.

HEPATOLOGY , cilt.74, sa.2, ss.1127, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Health-related Quality of Life of Liver Donors: A Prospective Longitudinal Study

hesimov i., KIRIMKER E. O., DUMAN B., KESKİN O., ÇETİNKAYA Ö. A., HAYME S., et al.

TRANSPLANTATION PROCEEDINGS , cilt.50, sa.10, ss.3076-3081, 2018 (SCI-Expanded)

Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy

Lutterkort G. L., Wranke A., Hengst J., Yurdaydin C., Stift J., Bremer B., et al.

JOURNAL OF VIRAL HEPATITIS , cilt.25, sa.11, ss.1384-1394, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population

Papatheodoridis G. V., Sypsa V., Dalekos G., Yurdaydin C., van Boemmel F., Buti M., et al.

JOURNAL OF HEPATOLOGY , cilt.68, sa.6, ss.1129-1136, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease

Yurdaydin C., KESKİN O., KALKAN Ç., KARAKAYA M. F., Caliskan A., Kabaçam G., et al.

JOURNAL OF INFECTIOUS DISEASES , cilt.217, sa.8, ss.1184-1192, 2018 (SCI-Expanded)

Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study

Yurdaydin C., KESKİN O., KALKAN Ç., KARAKAYA M. F., Caliskan A., KARATAYLI E., et al.

HEPATOLOGY , cilt.67, sa.4, ss.1224-1236, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B

Papatheodoridis G. V., İDİLMAN R., Dalekos G. N., Buti M., Chi H., van Boemmel F., et al.

HEPATOLOGY , cilt.66, sa.5, ss.1444-1453, 2017 (SCI-Expanded)

The association between gastroesophageal flap valve function and gastroesophageal reflux symptoms

KESKİN O., KALKAN Ç., Yaman A., TÜZÜN A. E., SOYKAN A. İ.

ACTA GASTRO-ENTEROLOGICA BELGICA , cilt.80, sa.4, ss.471-475, 2017 (SCI-Expanded)

Non-invasive fibrosis score for hepatitis delta

Lutterkort G. L., Wranke A., Yurdaydin C., Budde E., Westphal M., Lichtinghagen R., et al.

LIVER INTERNATIONAL , cilt.37, sa.2, ss.196-204, 2017 (SCI-Expanded)

Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up

KARAKAYA M. F., özer s., Kalkan C., Tuzun E. A., Caliskan A., Keskin O., et al.

ANTIVIRAL THERAPY , cilt.22, sa.7, ss.559-570, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence

İDİLMAN R., AKYILDIZ M., KESKİN O., güngör g., yılmaz t. u., KALKAN Ç., et al.

CLINICAL TRANSPLANTATION , cilt.30, sa.10, ss.1216-1221, 2016 (SCI-Expanded)

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

Papatheodoridis G., Dalekos G., Sypsa V., Yurdaydin C., Buti M., Goulis J., et al.

JOURNAL OF HEPATOLOGY , cilt.64, sa.4, ss.800-806, 2016 (SCI-Expanded)

A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease

İDİLMAN İ. S., Keskin O., CELIK A., Savas B., Elhan A. H., Idilman R., et al.

ACTA RADIOLOGICA , cilt.57, sa.3, ss.271-278, 2016 (SCI-Expanded)

Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome

KESKİN O., Wedemeyer H., TÜZÜN A. E., Zachou K., Deda X., Dalekos G. N., et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.13, sa.13, ss.2342-2351, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection a proof of concept randomised double blind placebo controlled phase 2A trial

Koh C., Canini L., Dahari H., Zhao X., Uprichard S. L., Williams V. H., et al.

Lancet Infectious Diseases , cilt.15, ss.1167-1174, 2015 (SCI-Expanded)

How to evaluate gastroesophageal sphincter incompetence

KESKİN O., KESKİN Ç.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.26, sa.5, ss.439, 2015 (SCI-Expanded)

Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy

SOYDAL Ç., KESKİN O., KÜÇÜK Ö., ÖZKAN E., BİLGİÇ M. S., İDİLMAN R., et al.

ANNALS OF NUCLEAR MEDICINE , cilt.29, sa.5, ss.426-430, 2015 (SCI-Expanded)

Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naive chronic hepatitis B patients in the real-world setting

İDİLMAN R., GÜNŞAR F., KORUK M., KESKİN O., MERAL C. E., GÜLŞEN M. T., et al.

JOURNAL OF VIRAL HEPATITIS , cilt.22, sa.5, ss.504-510, 2015 (SCI-Expanded)

Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

Papatheodoridis G. V., Dalekos G. N., Yurdaydin C., Buti M., Goulis J., Arends P., et al.

JOURNAL OF HEPATOLOGY , cilt.62, sa.2, ss.363-370, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Sequential development of acute autoimmune hepatitis may lead to a serious clinical picture in primary biliary cirrhosis

KESKİN O., İDİLMAN R.

European Journal Of Gastroenterology & Hepatology , cilt.27, ss.1228-1229, 2015 (SCI-Expanded)

Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta

KABAÇAM G., WEDEMEYER H., SAVAŞ B., KESKİN O., Dalekos G., TABAK Ö. F., et al.

LIVER INTERNATIONAL , cilt.34, sa.8, ss.1207-1215, 2014 (SCI-Expanded)

Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: Performance of phylogenetic analysis of the NS5B, E1, and 5 ' UTR regions in genotyping efficiency

Alagoz G. K., Karatayli S. C., KARATAYLI E., ÇELİK E., KESKİN O., DİNÇ B., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.25, sa.4, ss.405-410, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Autoimmune disease, tumor necrosis factor inhibitors and acute leukemia: possible associations in two patients?

ÖZEN M., KESKİN O., TOPÇUOĞLU P., ÖZTÜRK B., ÖZGÜL S., İLGEN U., et al.

LEUKEMIA & LYMPHOMA , cilt.55, sa.7, ss.1697-1698, 2014 (SCI-Expanded)

Public awareness of hepatitis B infection in Turkey as a model of universal effectiveness in health care policy

GÜRAKAR M., MALİK M., KESKİN O., İDİLMAN R.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.25, sa.3, ss.304-308, 2014 (SCI-Expanded)

Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease

Idilman I. S., KESKIN O., ELHAN A. H., IDILMAN R., Karcaaltincaba M.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , cilt.49, sa.5, ss.617-624, 2014 (SCI-Expanded)

Tumour necrosis factor-alpha, interleukin-10, interferon-gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta.

Karatayli S. C., ÜLGER Z., Ergul A., KESKİN O., KARATAYLI E., ALBAYRAK R., et al.

Journal of viral hepatitis , cilt.21, sa.4, ss.297-304, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B

KESKİN O., Ormeci A. C., BARAN B., KABAÇAM G., TÜZÜN A. E., KARATAYLI E., et al.

ANTIVIRAL THERAPY , cilt.19, sa.6, ss.543-550, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Effect of endogenous hypergastrinemia on gallbladder volume and ejection fraction in patients with autoimmune gastritis

YAKUT M., KESKİN O., SOYKAN A. İ.

Hepatobiliary & Pancreatic Diseases International , cilt.11, ss.527-531, 2012 (SCI-Expanded)

Clinical Profiles, Endoscopic and Laboratory Features and Associated Factors in Patients with Autoimmune Gastritis

SOYKAN A. İ., YAKUT M., KESKİN O., BEKTAŞ M.

DIGESTION , cilt.86, sa.1, ss.20-26, 2012 (SCI-Expanded)

No association of PTPN22 R620 W gene polymorphism with rheumatic heart disease and systemic lupus erythematosus

Aksoy R., DUMAN M. T., KESKİN O., Düzgün N.

MOLECULAR BIOLOGY REPORTS , cilt.38, sa.8, ss.5393-5396, 2011 (SCI-Expanded)

Cytotoxic T lymphocyte antigen 4 CTLA 4 polymorphism in patients with Behçet s disease

DÜZGÜN N., DUMAN M. T., KESKİN O., YONCA M., TUTKAK H.

Clinical and Experimental Rheumatology , cilt.28, ss.100, 2010 (SCI-Expanded)

Sarkoidoz Colyak Hastaligi Ve Derin Ven Trombozu Nadir Bir Birliktelik

ÇELİK G., ÇİLEDAĞ A., KESKİN O., ENSARİ A., Karabörk A., KAYA A.

Trakya Universitesi Tip Fakultesi Dergisi , cilt.28, ss.450-452, 2010 (SCI-Expanded)

The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis.

Dizdar E. A., Sekerel B. E., Keskın O., Kalaycı O., Adalıoglu G., Dogan C., et al.

International journal of pediatric otorhinolaryngology , cilt.71, ss.843-9, 2007 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient

Hasan A. A., Bulut E., KESKİN O.

Hepatology Forum , cilt.4, sa.2, ss.78-81, 2023 (Scopus)

A rare benign tumor of the liver mimicking angiosarcoma: Anastomosing hemangioma

Ismayilov R., BABAOĞLU B., KESKİN O.

Northern Clinics of Istanbul , cilt.10, sa.4, ss.524-526, 2023 (ESCI)

Behçet's Disease-related Budd–Chiari Syndrome Successfully Managed with anti-TNF Antibody: A Case Report and Review of the Literature

ERUL E., Uzun G. S., KÖKSAL D., KESKİN O., UYSAL S., İNKAYA A. Ç., et al.

European Journal of Case Reports in Internal Medicine , cilt.9, sa.8, 2022 (Scopus)

Drug-Associated Thrombocytopenia as a Rare and Devastating Side Effect of Octreotide in a Cirrhotic Patients: A Case Report and Current Literature Review

ALTINTOP S. E., GÜVEN A. T., KESKİN O.

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI , cilt.59, sa.3, ss.265-267, 2021 (ESCI)

Systemic Radiopharmaceutical Agents Sm 153 may be Dangerous in Hepatacellular Carcinoma

KESKİN O., SOYDAL Ç., DEDA X., MANTI B., TÜZÜN A. E.

World Journal of Nuclear Medicine , cilt.14, ss.51, 2015 (ESCI)

The Risk of Ileocolonic Perforation in Patients with Behçet s Disease Report of Three Cases and Review of the Literature

BEKTAŞ M., KALKAN Ç., SOYKAN A. İ., BOYVAT A., SAVAŞ B., GEÇİM İ. E., et al.

Journal of Gastrointestinal & Digestive System , cilt.4, 2014 (Hakemli Dergi)

An Interesting Case of Early Multifocal Gastric Cancer

KESKİN O., ÖRMECİ N.

Euroasian Journal of Hepato-Gastroenterology , cilt.2, ss.116-118, 2012 (Hakemli Dergi)

Effects of Helicobacter pylori infection and long term protonpump inhibitor use on enterochromaffin like cells

BEKTAŞ M., SARAÇ F. N., ÇETİNKAYA H., TÖRÜNER M., ERDEMLİ E., KESKİN O., et al.

Annals of Gastroenterology , cilt.25, ss.123-127, 2012 (Scopus)

Double Pylorus An Uncommon Endoscopic Finding

KESKİN O., SOYKAN A. İ.

Journal of Medical Cases , cilt.3, ss.172-173, 2012 (Hakemli Dergi)

Use of endoscopic band ligation for treatment of postpolypectomy hemorrhage

BEKTAŞ M., KESKİN O., KORKUT E., Üstün Y., Gupta V., Aniktar H., et al.

Endoskopi , cilt.19, ss.104-105, 2011 (Hakemli Dergi)

Treatment of Mallory Weiss syndrome using argon plasma coagulation

BEKTAŞ M., KORKUT E., İDİLMAN R., KESKİN O., Üstün Y., Gupta V., et al.

Endoskopi , cilt.19, ss.68-70, 2011 (Hakemli Dergi)

Toksik Megakolon ile İlgili Literatürün Gözden Geçirilmesi ve İlginç Bir Olgu Sunumu

KESKİN O., ERDEN G. A., Özden A.

Güncel Gastroenteroloji , cilt.11, ss.76-84, 2007 (Hakemli Dergi)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Comparison of Respiratory Muscle Strength, Functional Capacity and Peak Oxygen Uptake In Patients With End-Stage Liver Disease and Liver Transplantation

TAŞKIN B., VARDAR YAĞLI N., SAĞLAM M., ÇALIK KÜTÜKCÜ E., İNAL İNCE D., KESKİN O., et al.

European Respiratory Society Virtual Congress, 7 - 09 Eylül 2020, cilt.56, ss.2970

THE EFFECT OF PRETRANSPLANT INFECTIONS TO CLINICAL OUTCOME IN LIVE DONOR LIVER TRANSPLANT RECIPIENTS

ÇINAR G., AKDEMİR KALKAN İ., AZAP A., BALCI D., KIRIMKER E. O., KESKİN O., et al.

1st INTERNATIONAL TRANSPLANT NETWORK CONGRESS, 17 - 21 Ekim 2018

Prediction and Need for Surveillanceof Hepatocellular Carcinoma (HCC)Development after the First 5 Years of Entecavir(ETV) or Tenofovir Disoproxil Fumarate (TDF)Therapy in Caucasian Chronic Hepatitis B(CHB) Patients of the PAGE-B Cohort

Papatheodoridis G. V., Dalekos G. N., YURTAYDIN S. C., Sypsa V., van Bömmel F., Buti M., et al.

AASLD 2018, 9 - 13 Kasım 2018 Sürdürülebilir Kalkınma

Renal Problems in Patients with Solid Organ Transplanted

KESKİN O.

APASL 2018 SINGLE TOPIC CONFERENCE, 27 - 29 Eylül 2018

İNFLAMATUVAR BARSAK HASTALIĞI’NDASITOMEGALOVIRÜS (CMV) ENFEKSIYONU SIKLIĞIRISK FAKTÖRLERI VE KLINIK SEYIR

MANTI B., TÖRÜNER M., KESKİN O.

34. Ulusal Gastroenteroloji Haftası, Türkiye, 1 - 06 Aralık 2017

Cytomegalovirus infection in inflammatory bowel diseases in a large single center cohort

TÖRÜNER M., MANTI B., KESKİN O.

Advances in İnflammatory Bowel Diseases (AIBD) 2017, 9 - 11 Kasım 2017

Living Donor Liver Transplantation Using ALPPS Procedure: Case Report.

BALCI D., KIRIMKER E. O., KESKİN O., ÜSTÜNER E., YILMAZ A. A., KARADAĞ ERKOÇ S., et al.

18th Congress of the European Society for Organ Transplantation, 24 - 27 Eylül 2017

Living Donor Liver Transplantation using ALPPS procedure: case report

BALCI D., KIRIMKER E. O., KESKİN O., ÜSTÜNER E., YILMAZ A. A., KARADAĞ ERKOÇ S., et al.

18th Congress of the European Society for Organ Transplantation, Barcelona, İspanya, 24 - 27 Eylül 2017

A step-up approach for complex grfat biliary anatomy using microsurgical biliary reconstruction in living donor liver transplantation

BALCI D., KIRIMKER E. O., KOLOĞLU M., YILMAZ A. A., KARADAĞ ERKOÇ S., ADAKLI B., et al.

International Congress of ILTS, ELITALIcage, 24 - 27 Mayıs 2017

Viral Dominance patterns in hepatitis delta patients are associated with distinct systemic inflammatory patterns which influence response to interferon therapy

Lutterkort G. L., Wranke A., Hengst J., YURTAYDIN S. C., Weber K., Hardtke S., et al.

International Liver Congress 2017, 19 - 23 Nisan 2017, cilt.66 Sürdürülebilir Kalkınma

A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study

YURTAYDIN S. C., İDİLMAN R., KESKİN O., KALKAN Ç., KARAKAYA M. F., ÇALIŞKAN KARTAL A., et al.

International Liver Congress 2017, 19 - 23 Nisan 2017, cilt.66

Value of non-invasive fibrosis markers in chronic hepatitis D

KALKAN Ç., KARAKAYA M. F., KESKİN O., ÇALIŞKAN KARTAL A., KARATAYLI E., BOZDAYI A. M., et al.

INTERNATIONAL LIVER CONGRESS 2017, 19 - 23 Nisan 2017, cilt.66 Sürdürülebilir Kalkınma

The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis

YURTAYDIN S. C., İDİLMAN R., KALKAN Ç., KARAKAYA M. F., ÇALIŞKAN KARTAL A., KESKİN O., et al.

International Liver Congress, 19 - 23 Nisan 2017, cilt.66 Sürdürülebilir Kalkınma

In patients under treatment, chronic hepatitis D is a greater risk factor for hepatocellular carcinoma development than chronic hepatitis B

KESKİN O., İDİLMAN R., KALKAN Ç., KARAKAYA M. F., ÇALIŞKAN KARTAL A., YURTAYDIN S. C.

INTERNATIONAL LIVER CONGRESS 2017, 19 - 23 Nisan 2017 Sürdürülebilir Kalkınma

Exploring Optimal Dosing Of Lonafarnib With RitonavirFor The Treatment Of Chronic Delta Hepatitis InterimResults From The Lowr Hdv 2 Study

YURTAYDIN S. C., İDİLMAN R., KALKAN Ç., KARAKAYA M. F., ÇALIŞKAN KARTAL A., KESKİN O., et al.

AASLD 2016, 11 Kasım 2016 Sürdürülebilir Kalkınma

Hepatoselüler kanser gelişiminde kronik hepatit D Hepatit B ye göre daha büyük risk faktörüdür

KESKİN O., KARAKAYA M. F., KALKAN Ç., ÇALIŞKAN KARTAL A., İDİLMAN R., YURTAYDIN S. C.

Ulusal Gastroenteroloji Haftası 2016, Türkiye, 21 Kasım 2016 Sürdürülebilir Kalkınma

Viral Dominance patterns are associated with distinct systemic inflammatory patterns in patients with hepatitis delta

Lutterkort G. L., YURTAYDIN S. C., Wranke A., Hardtke S., KESKİN O., Manns M. P., et al.

AASLD 2016, 11 - 15 Kasım 2016 Sürdürülebilir Kalkınma

The risk of hepatocellular carcinoma HCC is decreasingafter the first 5 years of entecavir ETV or tenofovir TDF therapy in Caucasian chronic hepatitis B CHB patients

Papatheodoridis, G. V., YURTAYDIN S. C., Dalekos G. N., Buti M., Chi H., van Bömmel F., et al.

AASLD 2016, 11 Kasım 2016 Sürdürülebilir Kalkınma

The Prenylation Inhibitor Lonafarnib Can InducePost Treatment Alt Flares With Viral Clearance InPatients With Chronic Delta Hepatitis

YURTAYDIN S. C., İDİLMAN R., KALKAN Ç., KARAKAYA M. F., ÇALIŞKAN KARTAL A., KESKİN O., et al.

AASLD 2016, 11 Kasım 2016 Sürdürülebilir Kalkınma

Chronic hepatitis D is a greater risk factor for hepatocel lular carcinoma development than chronic hepatitis B

KESKİN O., KARAKAYA M. F., KALKAN Ç., ÇALIŞKAN KARTAL A., İDİLMAN R., YURTAYDIN S. C.

AASLD 2016, 11 Kasım 2016 Sürdürülebilir Kalkınma

Hepatocellular carcinoma HCC is the only factor affect ing the excellent survival of Caucasian chronic hepatitis B CHB patients with or without cirrhosis under long term entecavir ETV or tenofovir TDF therapy

Papatheodoridis G. V., Dalekos G. N., YURTAYDIN S. C., van Bömmel F., Buti M., Sypsa V., et al.

American Association of Study of Liver disease (AASLD) 2016, 11 - 15 Kasım 2016 Sürdürülebilir Kalkınma

The Role Of Genetic Variability Of PNPLA3 rs738409 On Predispotion To Non Alcoholic Fatty Liver Disease In Lean Patients

İDİLMAN R., ÖZEN KARATAYLI S. C., KARAKAYA M. F., KESKİN O., GÖZÜKARA B., SAVAŞ B., et al.

AASLD 2016, 11 Kasım 2016

Düşük viral yüklü HBV taşıyıcılarının prospektif analizi ve gerçek inaktif taşıyıcıların ayırımında ve takibinde kantitatif HbsAg ölçümünün yeri

KESKİN O., YAKUT M., KARAKAYA M. F., SEVEN G., KARATAYLI E., ÖZEN KARATAYLI S. C., et al.

32. Ulusal Gastroenteroloji Haftası, Türkiye, 25 - 29 Kasım 2015

Kronik delta hepatit tedavisinde uzun süreli interferon tedavisi süreğen virolojik yanıtı artırmakta ve doğal süreci iyileştirmektedir

KESKİN O., TÜZÜN A. E., KABAÇAM G., KARAKAYA M. F., ÇALIŞKAN KARTAL A., KARATAYLI E., et al.

32. Ulusal Gastroenteroloji Haftası, Türkiye, 25 - 29 Kasım 2015 Sürdürülebilir Kalkınma

Prolongation of interferon therapy increasesmaintained virological response rates and improves thenatural course of chronic delta hepatitis

KESKİN O., TÜZÜN A. E., KARAKAYA M. F., KALKAN Ç., ÇALIŞKAN KARTAL A., KARATAYLI E., et al.

AASLD 2015, 13 - 17 Kasım 2015 Sürdürülebilir Kalkınma

Etiology and Natural Course of End Stage Liver Disease in the Real World Setting

DEDA X., KALKAN Ç., KESKİN O., TÜZÜN A. E., YAKUT M., KILIÇ G., et al.

Digestive Disease Week 2015, 16 - 19 Mayıs 2015, cilt.148, ss.499

EXCELLENT 5 YEAR SURVIVAL IN CAUCASIAN CHRONICHEPATITIS B CHB PATIENTS WITH OR WITHOUT CIRRHOSIS UNDER LONG TERM ENTECAVIR ETV OR TENOFOVIR TDF THERAPY AND THE IMPACT OF HEPATOCELLULAR CARCINOMA HCC

Papatheodoridis G. V., Dalekos G. N., YURTAYDIN S. C., Buti M., Sypsa V., Goulis I., et al.

EASL 2015 50TH ANNUAL MEETING OF INTERNATIONAL LIVER CONGRESS, 22 - 26 Nisan 2015

Optimizing the prenylation inhibitor lonafarnib using ritonavir boosting in patients with chronic delta hepatitis

YURTAYDIN S. C., İDİLMAN R., Choong I., KALKAN Ç., KESKİN O., KARAKAYA M. F., et al.

EASL 2015 Annual Meeting of International Liver Congress, 22 - 26 Nisan 2015 Sürdürülebilir Kalkınma

On treatment HBsAg kinetics to predict long term HDV RNA response to peg IFNa treatment of hepatitis delta

WÖBSE M., Hardtke S., Stefanie E., Heidrich B., Bremer B., KESKİN O., et al.

EASL 2015 50th Annual Meeting of International Liver Congress, 22 - 26 Nisan 2015 Sürdürülebilir Kalkınma

UNDERSTANDING HEPATITIS DELTA VIRUS AND HBsAgKINETICS DURING TREATMENT WITH PRENYLATION INHIBITOR LONAFARNIB VIA MATHEMATICAL MODELING

Canini L., Koh C., Kotler S., Zhao X., Uprichard S. L., HaynesWilliams V., et al.

EASL 2015 ANNUAL MMETING OF INTERNATIONAL LİVER CONGRESS, 22 - 26 Nisan 2015

The role of genetic variability of pnpla3 rs738409 on histologicalprogression of non alcoholic fatty liver disease

İDİLMAN R., KESKİN O., ÖZEN KARATAYLI S. C., KABAÇAM G., TÜZÜN A. E., SAVAŞ B., et al.

24th Annual Conference of APASL, 2015 İSTANBUL, 12 - 15 Mart 2015

Uzun süreli tenofovir disoproksil fumarat tedavisi radyolojik siroz bulgularını geriletir

KESKİN O., UZUN Ç., ERDEN G. A., İDİLMAN R.

31. Ulusal Gastroenteroloji Haftası, Türkiye, 25 - 30 Kasım 2014

Budesonid tedavisine iyi yanıt veren atipik prezentasyonlu ileri yaş otoimmün pankreatit vakası

KESKİN O., BİR K., TÜZÜN A. E., BEKTAŞ M., ÇINAR K., BOZKAYA H.

31. Ulusal Gastroenteroloji Haftası, Türkiye, 25 - 30 Kasım 2014

Kronik delta hepatitte pegile interferon tedavisinde sonlanım prediktörü olarak serum HDV RNA

KESKİN O., KALKAN Ç., DEDA X., TÜZÜN A. E., KARAKAYA M. F., ZEUZEM S., et al.

31. ULUSAL GASTROENTEROLOJİ HAFTASI, Türkiye, 25 - 30 Kasım 2014

Yaygın lenfadenopatileri gelişen ilginç bir primer sklerozan kolanjit olgusu

KESKİN O., AVANOĞLU A., KARAKAYA M. F., TÜZÜN A. E., ÇINAR K., İDİLMAN R.

31. Ulusal Gastroenteroloji Haftası, Türkiye, 25 - 30 Kasım 2014